Cargando…
Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy
BACKGROUND: Mesenchymal stem cell (MSC)-based therapy is currently considered to be an effective treatment strategy for diabetes and hepatic disorders, such as liver cirrhosis and non-alcoholic fatty liver disease. Exosomes are important mediators of cellular connections, and increasing evidence has...
Autores principales: | He, Qin, Wang, Lingshu, Zhao, Ruxing, Yan, Fei, Sha, Sha, Cui, Chen, Song, Jia, Hu, Huiqing, Guo, Xinghong, Yang, Mengmeng, Cui, Yixin, Sun, Yujing, Sun, Zheng, Liu, Fuqiang, Dong, Ming, Hou, Xinguo, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278170/ https://www.ncbi.nlm.nih.gov/pubmed/32513303 http://dx.doi.org/10.1186/s13287-020-01731-6 |
Ejemplares similares
-
Retraction Note: Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy
por: He, Qin, et al.
Publicado: (2022) -
Mesenchymal stromal cells ameliorate diabetes‐induced muscle atrophy through exosomes by enhancing AMPK/ULK1‐mediated autophagy
por: Song, Jia, et al.
Publicado: (2023) -
Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation
por: He, Qin, et al.
Publicado: (2021) -
Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation
por: He, Qin, et al.
Publicado: (2022) -
Mesenchymal stromal cells ameliorate oxidative stress-induced islet endothelium apoptosis and functional impairment via Wnt4-β-catenin signaling
por: Wang, Lingshu, et al.
Publicado: (2017)